<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Burden of hypertension in Black individuals</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Burden of hypertension in Black individuals</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Burden of hypertension in Black individuals</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brent M Egan, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George L Bakris, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William B White, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karen Law, MD, FACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John P Forman, MD, MSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hypertension in Black patients as compared with White patients tends to be more common, to present earlier in life, and to be more severe [<a href="#rid1">1,2</a>]. In addition, progression from elevated blood pressure to hypertension is accelerated in Black patients [<a href="#rid3">3</a>]. The reasons for these observations are incompletely understood as the relative importance of environmental and genetic factors has not been established [<a href="#rid4">4,5</a>]. </p><p>The burden of hypertension in Black individuals is presented in this topic. The treatment of hypertension is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3869.html" rel="external">"Choice of drug therapy in primary (essential) hypertension"</a> and  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a>.)</p><p class="headingAnchor" id="H3515400408"><span class="h1">HYPERTENSION PREVALENCE AND CONTROL</span></p><p class="headingAnchor" id="H3744576237"><span class="h2">Prevalence disparity</span><span class="headingEndMark"> — </span>Hypertension is more prevalent in Black adults as compared with White adults [<a href="#rid6">6,7</a>]. Between 2017 and 2018 in the United States, for example, hypertension (defined as a systolic pressure ≥130 mmHg, diastolic pressure ≥80 mmHg, or use of antihypertensive drug therapy) was present in 57 percent of Black adults compared with 44 percent of White adults [<a href="#rid6">6</a>].</p><p>Important risk factors for hypertension among Black patients are largely related to adverse social determinants of health, including lower socioeconomic and educational status, concentrated poverty including lack of access to affordable and high-quality fresh food, and less healthy dietary patterns (eg, ingestion of a high-sodium/low-potassium diet) [<a href="#rid8">8</a>]. The potential importance of social determinants in the disproportionately high prevalence of hypertension among Black adults is reinforced by evidence that prevalent hypertension is comparable among Black and White adults in Cuba [<a href="#rid9">9</a>]. Moreover, African-origin populations with lower social strata in multiracial societies, such as the United States and South Africa, experience more hypertension than would be anticipated based upon anthropometric and measurable socioeconomic risk factors [<a href="#rid10">10</a>].</p><p>Another possible mechanism, which is also related to lower socioeconomic status, is poor maternal nutrition leading to low birth weight in the infant. Low birth weight has been associated with an increased risk of hypertension in adulthood, perhaps due in part to impaired kidney growth and development, with fewer functioning nephrons. Although low birth weight is more common in Black infants of mothers who are long-term residents of the United States, birth weights are not lower in Black infants born to mothers who are recent immigrants [<a href="#rid11">11</a>]. In addition, Black immigrants to the United States live eight to nine years longer than Black Americans who were born and are living in the United States [<a href="#rid12">12</a>]. These two observations raise the possibility that the social determinants play a key role, throughout the life course, in the excess prevalence of low birth weight, hypertension, and premature mortality among Black individuals. Low birth weight and adverse social determinants may also contribute to the greater predisposition among Black Americans to end-stage kidney disease (ESKD) [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/z/d/html/3853.html" rel="external">"Possible role of low birth weight in the pathogenesis of primary (essential) hypertension"</a>.)</p><p class="headingAnchor" id="H3334778004"><span class="h2">Control disparity</span><span class="headingEndMark"> — </span>In addition to the higher prevalence of hypertension, rates of hypertension control are lower among Black individuals [<a href="#rid14">14-17</a>]. As an example, in a nationally representative sample from the United States, hypertension control rates were 21 percent among Black adults and 24 percent among White adults [<a href="#rid14">14</a>]. The discrepancy in hypertension control was more pronounced comparing Black males with White males (18 versus 24 percent). Control rates are also lower among Black adults in Europe [<a href="#rid16">16,17</a>].</p><p>Differences in control rates are likely due, at least in part, to social determinants of health  (<a class="graphic graphic_figure graphicRef141921" href="/z/d/graphic/141921.html" rel="external">figure 1</a>). As an example, in a cohort of more than 14,000 Black and White adults who were treated for hypertension, the rate of control (defined as a blood pressure &lt;140/90 mmHg) was lower among Black individuals (64 versus 75 percent) [<a href="#rid18">18</a>]. Compared with White adults, Black adults had lower annual household incomes, lower education levels, were less likely to have health insurance, and resided in more economically disadvantaged neighborhoods and in regions with a shortage of health professionals. In adjusted analyses, differences in these social determinants accounted for one-third of the racial disparity in hypertension control.</p><p class="headingAnchor" id="H2"><span class="h1">RISK OF HYPERTENSIVE COMPLICATIONS</span></p><p class="headingAnchor" id="H26450720"><span class="h2">Disproportionately higher burden of complications in Black individuals</span><span class="headingEndMark"> — </span>Black patients with primary hypertension (formerly called "essential" hypertension) are at much greater risk of developing cardiovascular complications than other demographic groups. This is manifested, in comparison with White patients, by a threefold increase in overall cardiovascular mortality and a six- to sevenfold increase in mortality under the age of 50 years. Black patients are at significantly greater risk for stroke than White patients, especially at younger ages, due in part to the earlier onset and greater severity of hypertension. In addition, the risk of stroke at similar levels of blood pressure may be greater in Black adults than in White adults. In one study, for example, every 10 mmHg higher systolic blood pressure increased stroke risk by 24 percent in Black patients compared with 8 percent in White patients; this disparity in risk extended to individuals whose systolic blood pressure was as low as 120 mmHg [<a href="#rid19">19</a>]. Treatment of hypertension reduces but does not eliminate the racial difference in stroke [<a href="#rid20">20</a>]. </p><p>In addition to stroke, heart failure is more common among Black individuals. As an example, in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, Black adults had a 23 percent higher relative risk of heart failure hospitalization compared with White adults [<a href="#rid21">21</a>]; social determinants of heath that were more prevalent in Black individuals and that were also associated with heart failure hospitalization included low educational attainment, low annual household income, living in an area with a high poverty rate, poor public health infrastructure, and lack of health insurance.</p><p>Black patients also experience earlier development of hypertensive nephrosclerosis, as well as a substantially higher incidence of end-stage kidney disease (ESKD), than White patients, which is most prominent in the 25- to 45-year age group [<a href="#rid22">22-24</a>]. Black patients are also at increased risk for some other kidney diseases, particularly diabetic nephropathy. (See  <a class="medical medical_review" href="/z/d/html/3103.html" rel="external">"Diabetic kidney disease: Pathogenesis and epidemiology"</a>.)</p><p class="headingAnchor" id="H3717996550"><span class="h2">Reasons for higher complication burden</span><span class="headingEndMark"> — </span>The higher risk of hypertensive complications in Black individuals is likely due to more severe and poorly controlled hypertension, as well as the social determinants of health (eg, lower socioeconomic status, neighborhood deprivation, lower attained education, other lifestyle factors including lower diet quality), which themselves may account for greater severity of hypertension [<a href="#rid25">25</a>] and may lead to accelerated biological aging [<a href="#rid26">26,27</a>]. There may also be a genetic component, particularly with respect to the higher risk of kidney disease [<a href="#rid28">28-30</a>]. </p><p class="headingAnchor" id="H1860691037"><span class="h3">More severe hypertension</span><span class="headingEndMark"> — </span>The race-related difference in cardiovascular events can be largely mitigated by adequate antihypertensive therapy, suggesting an important role for more severe and less well-controlled hypertension in Black patients [<a href="#rid31">31,32</a>]. </p><p>In addition, nocturnal hypertension is more common in Black patients, thereby increasing the total daily blood pressure burden [<a href="#rid33">33</a>]. One study evaluated 62 Black and 72 White treated patients with hypertension who were matched for the same daytime blood pressure by ambulatory monitoring [<a href="#rid34">34</a>]. The mean blood pressure between 1 AM and 5 AM was 7 mmHg higher in the Black patients. Why this occurs is not known, but environmental causes are more likely than genetic causes [<a href="#rid35">35,36</a>].</p><p class="headingAnchor" id="H2260172283"><span class="h3">Inadequate antihypertensive therapy</span><span class="headingEndMark"> — </span>Inadequate antihypertensive therapy may result from therapeutic inertia and medication nonadherence:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Therapeutic inertia</strong> – Clinicians often fail to prescribe adequate pharmacotherapy to control hypertension (ie, therapeutic inertia); therapeutic inertia has a greater adverse impact on populations with a higher prevalence and greater severity of hypertension. In the United States, the average interval between office visits for uncontrolled hypertension is 14 weeks, and intensification of antihypertensive therapy occurs in approximately one out of seven visits [<a href="#rid37">37</a>]. This roughly translates into a required period of two years to adequately control blood pressure in patients with poor control.</p><p></p><p class="bulletIndent1">It is unclear whether or not therapeutic inertia occurs more frequently in the care of Black patients; some but not all studies identified racial differences [<a href="#rid38">38-40</a>]. One study, for example, followed more than 16,000 patients with uncontrolled hypertension for approximately two years and assessed rates of antihypertensive treatment intensification and the attainment of goal blood pressure [<a href="#rid38">38</a>]. In Black patients, treatment was intensified during approximately 25 percent of clinic visits in which blood pressure was elevated; in White patients, by contrast, treatment intensification occurred in approximately 33 percent of visits in which blood pressure was elevated. At the end of follow-up, fewer Black patients attained goal blood pressure as compared with White patients (66 versus 72 percent).</p><p></p><p class="bulletIndent1">However, when individuals with hypertension are followed frequently and effective medications, including <a class="drug drug_general" data-topicid="9255" href="/z/d/drug information/9255.html" rel="external">chlorthalidone</a>, are added and intensified promptly for uncontrolled blood pressure values, blood pressure control and clinical benefits are similar in Black individuals and White individuals. As an example, in the Systolic Blood Pressure Intervention Trial (SPRINT), attained blood pressures were similar among Black and White participants in both the standard and intensive treatment arms [<a href="#rid41">41,42</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medication nonadherence</strong> – Poor hypertension control may be related in part to antihypertensive medication nonadherence; medication nonadherence is more common in Black individuals and may be related to factors such as lower socioeconomic status, lack of health insurance, distrust in the medical system, greater reliance on alternative therapies [<a href="#rid43">43</a>], less frequent shared decision-making about treatment options [<a href="#rid44">44</a>], and lack of social support networks [<a href="#rid25">25</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h3">Social and environmental factors</span><span class="headingEndMark"> — </span>Socioeconomic and environmental factors are likely of paramount importance in explaining the disproportionately higher risk of uncontrolled hypertension and of hypertensive complications among Black individuals [<a href="#rid8">8,45-48</a>]. Among a cohort of Black and White American women, for example, lower levels of education, unemployment, lower income, and higher daily stress were all associated with cardiovascular risk, and all were more common in Black American women [<a href="#rid46">46</a>]. </p><p>Social disadvantages can lead to adverse lifestyle conditions associated with hypertension, such as an unhealthy diet and lack of regular exercise. As an example, Black Americans more frequently ingest a high-sodium/low-potassium diet [<a href="#rid47">47,48</a>], a combination that can both raise the blood pressure and increase the risk of cardiovascular complications. The incidence of salt sensitivity appears to be higher in Black patients than in White patients due perhaps to upward resetting of the set point for tubuloglomerular feedback [<a href="#rid49">49,50</a>]. Black individuals on average have lower values for plasma renin activity than White individuals, which has been associated with salt sensitivity of blood pressure [<a href="#rid51">51</a>]. Of note, potassium supplementation can eliminate racial differences in plasma renin activity and salt sensitivity [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/3877.html" rel="external">"Salt intake and hypertension"</a> and  <a class="medical medical_review" href="/z/d/html/3876.html" rel="external">"Potassium and hypertension"</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Possible genetic factors</span><span class="headingEndMark"> — </span>Despite similar degrees of blood pressure control, Black patients appear to remain at higher risk for certain cardiovascular complications of hypertension compared with White patients, including left ventricular hypertrophy and hypertensive kidney disease. In addition, as noted above, blood pressure control does not eliminate racial differences in stroke risk.</p><p>As an example, at the same level of blood pressure and total vascular resistance, both left ventricular mass index and renal vascular resistance are higher in hypertensive Black patients than in hypertensive White patients [<a href="#rid53">53</a>]. Furthermore, there appears to be as much as a four- to fivefold increase in the incidence of hypertensive kidney failure in Black patients that persists after the severity of hypertension, degree of hypertensive control, and socioeconomic status are taken into account [<a href="#rid54">54</a>]. Even seemingly adequate control of the hypertension may not be completely protective, as the kidney disease may continue to progress [<a href="#rid22">22,55</a>]. The increase in the incidence of ESKD among older Black patients contrasts with the declining rates of cardiovascular disease that correspond to the overall increase in treatment of hypertension [<a href="#rid56">56</a>].</p><p>It has been hypothesized that genetic differences may explain these observations. As an example, polymorphisms in the genes that encode apolipoprotein L1 (APOL1) [<a href="#rid28">28-30</a>] are found far more commonly in Black individuals compared with other populations. These genetic variations appear to confer a markedly increased risk for nondiabetic ESKD, including that due to hypertensive nephrosclerosis and focal segmental glomerulosclerosis (FSGS) [<a href="#rid28">28,29</a>], as well as human immunodeficiency virus (HIV)-associated nephropathy [<a href="#rid57">57</a>]. The APOL1 variant may have had a survival advantage in Africa due to enhanced defense against sleeping sickness [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/3049.html" rel="external">"Focal segmental glomerulosclerosis: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/14026.html" rel="external">"HIV-associated nephropathy (HIVAN)"</a>.)</p><p>However, there are some data that these racial differences in left ventricular mass, kidney function, and cardiovascular risk, despite similar blood pressure control, are <strong>not</strong> genetic in origin. In SPRINT, for example, 2466 self-described Black hypertensive patients underwent genotyping, and their degree of West African ancestry (which ranged from 30 to 100 percent) was determined using previously established ancestry-informative genetic markers [<a href="#rid58">58</a>]. Achievement of blood pressure targets was not affected by ancestry. During more than three years of follow-up, changes in left ventricular mass and kidney function were similar across individuals with different degrees of West African ancestry. In addition, those with the highest degree of West African ancestry had a lower risk of cardiovascular events.</p><p class="headingAnchor" id="H5"><span class="h1">GOAL BLOOD PRESSURE</span><span class="headingEndMark"> — </span>In summary, effective antihypertensive therapy is particularly important in Black patients. A discussion of which antihypertensive drugs should be used can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/3869.html" rel="external">"Choice of drug therapy in primary (essential) hypertension"</a>.)</p><p>The optimal blood pressure in Black patients is similar to that in other patients and depends in part upon comorbid conditions and overall cardiovascular risk. These issues are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a>.)</p><p>The two largest studies to examine goal blood pressure in Black patients were the Systolic Blood Pressure Intervention Trial (SPRINT) and the African American Study of Kidney Disease and Hypertension (AASK). SPRINT enrolled individuals at high cardiovascular risk, whereas AASK enrolled patients with hypertensive nephrosclerosis:</p><p class="bulletIndent1"><span class="glyph">●</span>SPRINT, discussed in detail elsewhere, assigned 9361 patients, including 2802 non-Hispanic Black patients, to a systolic blood pressure goal of &lt;120 mmHg or a goal of &lt;140 mmHg [<a href="#rid59">59</a>]. The benefit from more intensive blood pressure lowering was similar in Black and other racial subgroups. (See  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension", section on 'Patients with established atherosclerotic cardiovascular disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AASK included 1094 African Americans with long-standing hypertension, otherwise unexplained slowly progressive chronic kidney disease, and mild proteinuria (mean of approximately 500 to 600 mg/day but a median of approximately 100 mg/day) [<a href="#rid60">60</a>]; this pattern in Black patients is almost always associated with histologic changes compatible with nephrosclerosis as the sole disease [<a href="#rid61">61</a>]. The patients were allocated to one of three drugs, <a class="drug drug_general" data-topicid="9851" href="/z/d/drug information/9851.html" rel="external">ramipril</a> (463 patients), <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a> (441 patients), or <a class="drug drug_general" data-topicid="8627" href="/z/d/drug information/8627.html" rel="external">amlodipine</a> (217 patients), and to one of two blood pressure goals, 125/75 or 140/90 mmHg. The effect of the goal blood pressure in AASK is presented separately. (See  <a class="medical medical_review" href="/z/d/html/7169.html" rel="external">"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", section on 'AASK trial of goal blood pressure'</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Recommendations by others</span><span class="headingEndMark"> — </span>In November 2010, a consensus statement concerning the management of high blood pressure in African Americans was published by the International Society on Hypertension in Black patients [<a href="#rid62">62</a>]. For those with <strong>uncomplicated</strong> primary hypertension (formerly called "essential" hypertension), a goal blood pressure less than 135/85 mmHg was considered a reasonable target. A lower goal of less than 130/80 mmHg was recommended in patients at increased risk, such as those with atherosclerotic cardiovascular disease, diabetes, or proteinuric chronic kidney disease. However, the 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines recommended a blood pressure target of less than 130/80 mmHg and did not make separate recommendations for Black patients [<a href="#rid63">63</a>].</p><p>Our recommendations on goal blood pressure, and the ACC/AHA recommendations, are presented separately. (See  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a>.)</p><p class="headingAnchor" id="H16514135"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Burden of hypertension</strong> – Hypertension develops earlier in life and is more common and more severe in Black as compared with White patients. Black patients are less likely to have controlled blood pressure and are at greater risk of developing hypertensive complications compared with White patients. (See <a class="local">'Introduction'</a> above and <a class="local">'Hypertension prevalence and control'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reasons for increased burden</strong> – The increased risk of uncontrolled hypertension and hypertensive complications is likely due to multiple factors including the increased severity of hypertension, inadequate antihypertensive therapy, social determinants of health (eg, environmental and socioeconomic factors)  (<a class="graphic graphic_figure graphicRef141921" href="/z/d/graphic/141921.html" rel="external">figure 1</a>), and possibly genetic factors. (See <a class="local">'Risk of hypertensive complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goal blood pressure</strong> – The optimal goal blood pressure in Black patients is similar to that in other patients and depends in part upon comorbid conditions and overall cardiovascular risk. Goal blood pressure is discussed separately:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Goal blood pressure'</a> above.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/7169.html" rel="external">"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults", section on 'Blood pressure goal'</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/3829.html" rel="external">"Treatment of hypertension in patients with diabetes mellitus"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Carson AP, Howard G, Burke GL, et al. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension 2011; 57:1101.</a></li><li><a class="nounderline abstract_t">Bundy JD, Mills KT, Chen J, et al. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data. JAMA Cardiol 2018; 3:572.</a></li><li><a class="nounderline abstract_t">Selassie A, Wagner CS, Laken ML, et al. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension 2011; 58:579.</a></li><li><a class="nounderline abstract_t">McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med 2009; 150:505.</a></li><li><a class="nounderline abstract_t">Berenson GS, Chen W, Dasmahapatra P, et al. Stimulus response of blood pressure in black and white young individuals helps explain racial divergence in adult cardiovascular disease: the Bogalusa Heart Study. J Am Soc Hypertens 2011; 5:230.</a></li><li><a class="nounderline abstract_t">Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018. NCHS Data Brief 2020; :1.</a></li><li><a class="nounderline abstract_t">Muntner P, Carey RM, Gidding S, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation 2018; 137:109.</a></li><li><a class="nounderline abstract_t">Howard G, Cushman M, Moy CS, et al. Association of Clinical and Social Factors With Excess Hypertension Risk in Black Compared With White US Adults. JAMA 2018; 320:1338.</a></li><li><a class="nounderline abstract_t">Ordúñez P, Kaufman JS, Benet M, et al. Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health 2013; 13:169.</a></li><li><a class="nounderline abstract_t">Cooper RS, Forrester TE, Plange-Rhule J, et al. Elevated hypertension risk for African-origin populations in biracial societies: modeling the Epidemiologic Transition Study. J Hypertens 2015; 33:473.</a></li><li><a class="nounderline abstract_t">Taylor CA, Sarathchandra D. Migrant Selectivity or Cultural Buffering? Investigating the Black Immigrant Health Advantage in Low Birth Weight. J Immigr Minor Health 2016; 18:390.</a></li><li><a class="nounderline abstract_t">Singh GK, Miller BA. Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health 2004; 95:I14.</a></li><li><a class="nounderline abstract_t">Lackland DT, Bendall HE, Osmond C, et al. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med 2000; 160:1472.</a></li><li><a class="nounderline abstract_t">Ostchega Y, Zhang G, Hughes JP, Nwankwo T. Factors Associated With Hypertension Control in US Adults Using 2017 ACC/AHA Guidelines: National Health and Nutrition Examination Survey 1999-2016. Am J Hypertens 2018; 31:886.</a></li><li><a class="nounderline abstract_t">Muntner P, Hardy ST, Fine LJ, et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018. JAMA 2020; 324:1190.</a></li><li><a class="nounderline abstract_t">van der Linden EL, Couwenhoven BN, Beune EJAJ, et al. Hypertension awareness, treatment and control among ethnic minority populations in Europe: a systematic review and meta-analysis. J Hypertens 2021; 39:202.</a></li><li><a class="nounderline abstract_t">Tapela N, Collister J, Clifton L, et al. Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK. Open Heart 2021; 8.</a></li><li><a class="nounderline abstract_t">Akinyelure OP, Jaeger BC, Oparil S, et al. Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. Hypertension 2023; 80:1403.</a></li><li><a class="nounderline abstract_t">Howard G, Lackland DT, Kleindorfer DO, et al. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med 2013; 173:46.</a></li><li><a class="nounderline abstract_t">Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982; 247:633.</a></li><li><a class="nounderline abstract_t">Pinheiro LC, Reshetnyak E, Sterling MR, et al. Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study. Circ Cardiovasc Qual Outcomes 2020; 13:e006438.</a></li><li><a class="nounderline abstract_t">Bergman S, Key BO, Kirk KA, et al. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996; 27:341.</a></li><li><a class="nounderline abstract_t">Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US minority groups. Am J Kidney Dis 1992; 19:397.</a></li><li><a class="nounderline abstract_t">Bock F, Stewart TG, Robinson-Cohen C, et al. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study. BMC Nephrol 2019; 20:308.</a></li><li><a class="nounderline abstract_t">Ferdinand KC, Yadav K, Nasser SA, et al. Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence. J Clin Hypertens (Greenwich) 2017; 19:1015.</a></li><li><a class="nounderline abstract_t">Lawrence KG, Kresovich JK, O'Brien KM, et al. Association of Neighborhood Deprivation With Epigenetic Aging Using 4 Clock Metrics. JAMA Netw Open 2020; 3:e2024329.</a></li><li><a class="nounderline abstract_t">Duru OK, Harawa NT, Kermah D, Norris KC. Allostatic load burden and racial disparities in mortality. J Natl Med Assoc 2012; 104:89.</a></li><li><a class="nounderline abstract_t">Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369:2183.</a></li><li><a class="nounderline abstract_t">Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841.</a></li><li><a class="nounderline abstract_t">Genovese G, Tonna SJ, Knob AU, et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010; 78:698.</a></li><li><a class="nounderline abstract_t">Ooi WL, Budner NS, Cohen H, et al. Impact of race on treatment response and cardiovascular disease among hypertensives. Hypertension 1989; 14:227.</a></li><li><a class="nounderline abstract_t">Otten MW Jr, Teutsch SM, Williamson DF, Marks JS. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA 1990; 263:845.</a></li><li><a class="nounderline abstract_t">Prather AA, Blumenthal JA, Hinderliter AL, Sherwood A. Ethnic differences in the effects of the DASH diet on nocturnal blood pressure dipping in individuals with high blood pressure. Am J Hypertens 2011; 24:1338.</a></li><li><a class="nounderline abstract_t">Hebert LA, Agarwal G, Ladson-Wofford SE, et al. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans. J Am Soc Nephrol 1996; 7:2130.</a></li><li><a class="nounderline abstract_t">Booth JN III, Li M, Shimbo D, et al. West African Ancestry and Nocturnal Blood Pressure in African Americans: The Jackson Heart Study. Am J Hypertens 2018; 31:706.</a></li><li><a class="nounderline abstract_t">Wilson DK, Sica DA, Miller SB. Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents. Am J Hypertens 1999; 12:159.</a></li><li><a class="nounderline abstract_t">Bellows BK, Ruiz-Negrón N, Bibbins-Domingo K, et al. Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals. Circ Cardiovasc Qual Outcomes 2019; 12:e005624.</a></li><li><a class="nounderline abstract_t">Fontil V, Pacca L, Bellows BK, et al. Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control. JAMA Cardiol 2022; 7:204.</a></li><li><a class="nounderline abstract_t">Shelley D, Tseng TY, Andrews H, et al. Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens 2011; 24:1318.</a></li><li><a class="nounderline abstract_t">Cummings DM, Adams A, Halladay J, et al. Race-Specific Patterns of Treatment Intensification Among Hypertensive Patients Using Home Blood Pressure Monitoring: Analysis Using Defined Daily Doses in the Heart Healthy Lenoir Study. Ann Pharmacother 2019; 53:333.</a></li><li><a class="nounderline abstract_t">Still CH, Rodriguez CJ, Wright JT Jr, et al. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial. Am J Hypertens 2017; 31:97.</a></li><li><a class="nounderline abstract_t">Turner ST, Schwartz GL, Chapman AB, et al. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens 2010; 23:1014.</a></li><li><a class="nounderline abstract_t">Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med 1996; 43:903.</a></li><li><a class="nounderline abstract_t">Ratanawongsa N, Zikmund-Fisher BJ, Couper MP, et al. Race, ethnicity, and shared decision making for hyperlipidemia and hypertension treatment: the DECISIONS survey. Med Decis Making 2010; 30:65S.</a></li><li><a class="nounderline abstract_t">Milani RV, Price-Haywood EG, Burton JH, et al. Racial Differences and Social Determinants of Health in Achieving Hypertension Control. Mayo Clin Proc 2022; 97:1462.</a></li><li><a class="nounderline abstract_t">Davis SK, Gebreab S, Quarells R, Gibbons GH. Social determinants of cardiovascular health among black and white women residing in Stroke Belt and Buckle regions of the South. Ethn Dis 2014; 24:133.</a></li><li><a class="nounderline abstract_t">Hedayati SS, Minhajuddin AT, Ijaz A, et al. Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences. Clin J Am Soc Nephrol 2012; 7:315.</a></li><li><a class="nounderline abstract_t">Frisancho AR, Leonard WR, Bollettino LA. Blood pressure in blacks and whites and its relationship to dietary sodium and potassium intake. J Chronic Dis 1984; 37:515.</a></li><li><a class="nounderline abstract_t">Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. Kidney Int 2004; 65:361.</a></li><li><a class="nounderline abstract_t">Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 2004; 43:707.</a></li><li><a class="nounderline abstract_t">Langford HG, Cushman WC, Hsu H. Chronic effect of KCl on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes. Am J Hypertens 1991; 4:399.</a></li><li><a class="nounderline abstract_t">Morris RC Jr, Sebastian A, Forman A, et al. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18.</a></li><li><a class="nounderline abstract_t">Kizer JR, Arnett DK, Bella JN, et al. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 2004; 43:1182.</a></li><li><a class="nounderline abstract_t">Lopes AA, Port FK. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. Am J Kidney Dis 1995; 25:350.</a></li><li><a class="nounderline abstract_t">Rostand SG, Brown G, Kirk KA, et al. Renal insufficiency in treated essential hypertension. N Engl J Med 1989; 320:684.</a></li><li><a class="nounderline abstract_t">Li S, McAlpine DD, Liu J, et al. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther 2004; 11:5.</a></li><li><a class="nounderline abstract_t">Friedman DJ, Pollak MR. Genetics of kidney failure and the evolving story of APOL1. J Clin Invest 2011; 121:3367.</a></li><li><a class="nounderline abstract_t">Rao S, Segar MW, Bress AP, et al. Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT). JAMA Cardiol 2020.</a></li><li><a class="nounderline abstract_t">SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015; 373:2103.</a></li><li><a class="nounderline abstract_t">Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285:2719.</a></li><li><a class="nounderline abstract_t">Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 1997; 51:244.</a></li><li><a class="nounderline abstract_t">Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010; 56:780.</a></li><li><a class="nounderline abstract_t">Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71:e13.</a></li></ol></div><div id="topicVersionRevision">Topic 3855 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21502561" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29800138" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21911708" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Progression is accelerated from prehypertension to hypertension in blacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19380852" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21493177" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Stimulus response of blood pressure in black and white young individuals helps explain racial divergence in adult cardiovascular disease: the Bogalusa Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32487290" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29133599" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30285178" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Association of Clinical and Social Factors With Excess Hypertension Risk in Black Compared With White US Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23433343" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25426566" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Elevated hypertension risk for African-origin populations in biracial societies: modeling the Epidemiologic Transition Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25787352" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Migrant Selectivity or Cultural Buffering? Investigating the Black Immigrant Health Advantage in Low Birth Weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15191127" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Health, life expectancy, and mortality patterns among immigrant populations in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10826460" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29617894" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Factors Associated With Hypertension Control in US Adults Using 2017 ACC/AHA Guidelines: National Health and Nutrition Examination Survey 1999-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32902588" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32925300" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Hypertension awareness, treatment and control among ethnic minority populations in Europe: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33707223" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37082942" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23229778" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Racial differences in the impact of elevated systolic blood pressure on stroke risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7033578" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32703013" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604702" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1585925" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : End-stage renal disease in US minority groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31390993" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28856834" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33146735" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Association of Neighborhood Deprivation With Epigenetic Aging Using 4 Clock Metrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22708252" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Allostatic load burden and racial disparities in mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24206458" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : APOL1 risk variants, race, and progression of chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20647424" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Association of trypanolytic ApoL1 variants with kidney disease in African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20668430" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2767755" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Impact of race on treatment response and cardiovascular disease among hypertensives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2296146" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The effect of known risk factors on the excess mortality of black adults in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21866183" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ethnic differences in the effects of the DASH diet on nocturnal blood pressure dipping in individuals with high blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8915972" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29528363" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : West African Ancestry and Nocturnal Blood Pressure in African Americans: The Jackson Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10090343" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31163981" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34878499" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21866185" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Predictors of blood pressure control among hypertensives in community health centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30282468" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Race-Specific Patterns of Treatment Intensification Among Hypertensive Patients Using Home Blood Pressure Monitoring: Analysis Using Defined Daily Doses in the Heart Healthy Lenoir Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28985268" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20725057" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8888461" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881155" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Race, ethnicity, and shared decision making for hyperlipidemia and hypertension treatment: the DECISIONS survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35868877" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Racial Differences and Social Determinants of Health in Achieving Hypertension Control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24804357" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Social determinants of cardiovascular health among black and white women residing in Stroke Belt and Buckle regions of the South.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22114147" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Association of urinary sodium/potassium ratio with blood pressure: sex and racial differences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6746843" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Blood pressure in blacks and whites and its relationship to dietary sodium and potassium intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14717906" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14967834" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Urinary potassium excretion and sodium sensitivity in blacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2069772" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Chronic effect of KCl on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9931076" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Normotensive salt sensitivity: effects of race and dietary potassium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15123573" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7847366" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2922014" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Renal insufficiency in treated essential hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14730534" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21881214" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Genetics of kidney failure and the evolving story of APOL1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33185651" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-Reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26551272" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A Randomized Trial of Intensive versus Standard Blood-Pressure Control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11386927" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8995739" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20921433" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29133356" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
